VICTOR KRASNYKH to Cell Line, Tumor
This is a "connection" page, showing publications VICTOR KRASNYKH has written about Cell Line, Tumor.
Connection Strength
0.084
-
Development of a targeted gene vector platform based on simian adenovirus serotype 24. J Virol. 2010 Oct; 84(19):10087-101.
Score: 0.031
-
Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters. Proc Natl Acad Sci U S A. 2013 Mar 05; 110(10):E869-77.
Score: 0.009
-
Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT. Proc Natl Acad Sci U S A. 2011 Jan 25; 108(4):1603-8.
Score: 0.008
-
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity. Cancer Gene Ther. 2009 Mar; 16(3):256-65.
Score: 0.007
-
Cell cycle arrest and apoptosis induced by SART-1 gene transduction. Anticancer Res. 2005 May-Jun; 25(3B):1983-90.
Score: 0.005
-
Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer. J Gastroenterol. 2005 Jan; 40(1):31-42.
Score: 0.005
-
Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment. Cancer Res. 2004 Jun 15; 64(12):4319-27.
Score: 0.005
-
Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo. Virology. 2004 Mar 01; 320(1):121-34.
Score: 0.005
-
Blood-based screening and light based imaging for the early detection and monitoring of ovarian cancer xenografts. Technol Cancer Res Treat. 2003 Apr; 2(2):171-80.
Score: 0.005
-
Approaches to utilize mesenchymal progenitor cells as cellular vehicles. Stem Cells. 2003; 21(4):389-404.
Score: 0.005